MD Pediatrix Medical Group, Inc.

NYSE mednax.com


$ 16.21 $ -0.25 (-1.52 %)    

Thursday, 16-Oct-2025 15:59:58 EDT
QQQ $ 593.37 $ 0.00 (0 %)
DIA $ 456.43 $ 0.00 (0 %)
SPY $ 654.63 $ 0.00 (0 %)
TLT $ 91.48 $ 0.00 (0 %)
GLD $ 399.00 $ 0.00 (0 %)
$ 16.2
$ 16.44
$ 6.70 x 1
$ 16.60 x 4
-- - --
$ 11.84 - $ 18.22
673,026
na
1.41B
$ 0.90
$ 12.77
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-20-2025 12-31-2024 10-K
4 11-01-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-20-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 02-17-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 04-28-2022 03-31-2022 10-Q
15 02-17-2022 12-31-2021 10-K
16 10-28-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-07-2021 03-31-2021 10-Q
19 02-18-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 07-30-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-20-2020 12-31-2019 10-K
24 11-01-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-14-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 02-14-2018 12-31-2017 10-K
32 11-01-2017 09-30-2017 10-Q
33 07-28-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 02-10-2017 12-31-2016 10-K
36 10-27-2016 09-30-2016 10-Q
37 07-28-2016 06-30-2016 10-Q
38 04-28-2016 03-31-2016 10-Q
39 02-11-2016 12-31-2015 10-K
40 10-29-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 leerink-partners-maintains-market-perform-on-pediatrix-medical-group-raises-price-target-to-17

Leerink Partners analyst Whit Mayo maintains Pediatrix Medical Group (NYSE:MD) with a Market Perform and raises the price ta...

 pediatrix-medical-group-authorizes-250m-share-repurchase-program

Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its Board of Directors ...

 ubs-maintains-neutral-on-pediatrix-medical-group-raises-price-target-to-165

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16 to $16.5.

 pediatrix-medical-group-q2-adj-eps-053-beats-042-estimate-sales-468844m-beat-464324m-estimate

Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $...

 ubs-maintains-neutral-on-pediatrix-medical-group-lowers-price-target-to-16

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and lowers the price target from $18.5 to $16.

 macquarie-maintains-outperform-on-pediatrix-medical-group-raises-price-target-to-20

Macquarie analyst Tao Qiu maintains Pediatrix Medical Group (NYSE:MD) with a Outperform and raises the price target from $19...

 pediatrix-medical-group-q1-adj-eps-033-beats-024-estimate-sales-45836m-beat-45150m-estimate

Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $...

 truist-securities-maintains-hold-on-pediatrix-medical-group-lowers-price-target-to-16

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and lowers the price targe...

 ubs-maintains-neutral-on-pediatrix-medical-group-raises-price-target-to-185

UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $...

 truist-securities-maintains-hold-on-pediatrix-medical-group-raises-price-target-to-18

Truist Securities analyst David Macdonald maintains Pediatrix Medical Group (NYSE:MD) with a Hold and raises the price targe...

 pediatrix-q4-beats-estimates-as-operational-improvements-drive-performance

Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company project...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION